The expression levels of NAT10 protein in breast cancer, ovarian cancer, colon cancer, renal clear cell carcinoma, endometrial carcinoma, lung cancer, head and neck squamous cell carcinoma, pancreatic cancer, glioblastoma and liver cancer were greatly higher compared to those in normal tissues (Fig. 6b). This evidence concerns the gene NAT10 and breast cancer.